Condition
Elder
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (3)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06397079Not ApplicableCompletedPrimary
Oral Care Program for Residients in Long-term Care Facility
NCT06169085Phase 1CompletedPrimary
Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants
NCT06157450Phase 1CompletedPrimary
Pharmacokinetics of ZSP1273 in Elder Participants
NCT05826249Phase 1UnknownPrimary
Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects
NCT05158959UnknownPrimary
Association Between Renal Reserve Function and Progression of Renal Function to Predict CKD Risk in Thai Elderly
Showing all 5 trials